Wave life sciences ltd. (WVE)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Dec'14
Assets
Current assets:
Cash and cash equivalents

120,900

147,161

209,009

252,906

287,567

174,819

210,489

241,431

110,491

142,503

168,464

197,394

129,484

150,293

169,015

181,765

153,397

161,220

1,048

Current portion of accounts receivable

-

20,000

20,000

20,000

10,000

10,000

10,000

15,000

-

1,000

-

-

-

-

2,500

-

-

-

200

Prepaid expenses

9,999

9,626

-

-

-

6,587

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

18,843

8,689

-

-

-

10,867

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

21,249

16,685

17,464

-

12,672

11,243

7,470

6,985

5,370

3,830

3,296

1,483

625

2,176

580

146

103

Deferred tax assets

-

-

-

-

-

-

-

-

-

-

-

-

-

214

-

-

23

18

64

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

72

Total current assets

149,791

185,476

250,258

289,591

315,031

202,273

233,161

267,674

117,961

150,488

173,834

201,224

132,780

151,990

172,140

183,941

154,000

161,384

1,487

Long-term assets:
Accounts receivable, net of current portion

30,000

30,000

30,000

30,000

50,000

50,000

50,000

50,000

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

34,986

36,368

37,204

38,363

39,929

39,931

37,722

32,384

28,778

27,334

24,584

20,775

14,296

8,607

6,693

5,093

3,218

2,789

1,269

Operating lease right-of-use assets

17,659

18,101

18,527

18,937

19,333

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax assets

-

-

-

-

-

-

-

-

-

-

-

774

774

560

32

192

192

192

182

Restricted cash

3,649

3,647

3,643

3,637

3,631

3,625

3,620

3,616

3,612

3,610

3,608

3,606

3,604

3,601

1,055

1,055

1,055

1,055

0

Other assets

2,487

10,658

7,580

5,019

2,688

111

74

69

70

411

60

53

53

53

53

57

57

4

-

Total long-term assets

88,781

98,774

96,954

95,956

115,581

93,667

91,416

86,069

32,460

31,355

-

-

-

12,821

-

-

-

-

-

Total assets

238,572

284,250

347,212

385,547

430,612

295,940

324,577

353,743

150,421

181,843

202,086

226,432

151,507

164,811

179,973

190,338

158,522

165,424

2,938

Liabilities, Series A preferred shares and shareholders’ equity
Current liabilities:
Accounts payable

16,486

9,073

20,219

11,464

14,577

13,089

11,961

7,151

8,014

7,598

4,705

7,983

7,397

4,943

3,825

3,899

2,437

2,811

125

Accrued expenses and other current liabilities

10,994

16,185

13,738

11,632

8,490

14,736

9,518

8,494

6,461

8,898

6,953

4,589

3,789

4,434

4,833

2,161

1,271

945

605

Current portion of capital lease obligation

-

-

-

-

-

-

-

-

-

16

31

47

62

62

62

62

62

62

-

Current portion of deferred rent

-

-

-

-

-

115

90

80

70

60

50

-

-

-

-

-

-

-

-

Current portion of deferred revenue

88,044

89,652

96,322

97,964

105,891

100,945

103,229

27,294

1,275

1,275

2,705

2,705

2,705

2,705

2,705

2,500

-

-

152

Deferred tax liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

-

-

-

Current portion of lease incentive obligation

-

-

-

-

-

1,156

997

762

478

344

678

231

117

11

-

-

-

-

-

Current portion of operating lease liability

3,357

3,243

3,132

3,024

2,919

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

118,881

118,153

133,411

124,084

131,877

130,041

125,795

43,781

16,298

18,191

15,122

15,555

14,070

12,155

11,425

8,647

3,770

3,818

882

Long-term liabilities:
Capital lease obligation, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

16

31

47

62

78

-

Deferred rent, net of current portion

-

-

-

-

-

5,132

5,084

4,864

4,591

4,214

3,837

2,864

1,711

680

-

-

-

-

-

Deferred revenue, net of current portion

60,913

63,466

59,196

60,483

60,184

68,156

69,494

149,921

5,819

7,241

6,283

6,959

7,635

8,311

8,987

7,083

-

-

-

Lease incentive obligation, net of current portion

-

-

-

-

-

9,247

8,229

6,474

4,185

3,094

2,093

2,197

1,075

116

-

-

-

-

-

Operating lease liability, net of current portion

28,425

29,304

30,165

30,985

31,782

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

1,621

1,721

1,793

1,897

2,039

2,142

1,495

1,533

1,605

1,619

1,021

2,071

2,055

796

522

409

295

163

29

Total long-term liabilities

90,959

94,491

91,154

93,365

94,005

84,677

84,302

162,792

16,200

16,168

13,234

14,091

12,476

9,919

9,540

7,539

357

241

29

Total liabilities

209,840

212,644

224,565

217,449

225,882

214,718

210,097

206,573

32,498

34,359

28,356

29,646

26,546

22,074

20,965

16,186

4,127

4,059

911

Series A preferred shares, no par value; 3,901,348 shares issued and outstanding at March 31, 2020 and December 31, 2019

7,874

7,874

7,874

7,874

7,874

7,874

7,874

7,874

7,874

7,874

7,874

7,874

7,874

7,874

-

-

-

-

7,874

Shareholders’ equity:
Ordinary shares, no par value; 34,601,582 and 34,340,690 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

540,161

539,547

538,790

538,537

538,414

375,148

374,502

373,151

311,591

310,038

309,434

309,355

215,808

215,602

215,505

215,372

185,344

185,344

9,973

Additional paid-in capital

61,276

57,277

52,290

47,270

42,113

37,768

33,757

30,147

26,602

22,172

18,995

15,996

13,028

10,029

7,568

5,318

4,048

3,182

-

Accumulated other comprehensive income

273

267

282

280

250

153

181

201

165

116

-272

-273

-276

-291

84

76

52

41

56

Accumulated deficit

-580,852

-533,359

-476,589

-425,863

-383,921

-339,721

-301,834

-264,203

-228,309

-192,716

-162,301

-136,166

-111,473

-90,477

-72,023

-54,488

-42,923

-35,076

-15,876

Total shareholders’ equity

20,858

63,732

114,773

160,224

196,856

73,348

106,606

139,296

110,049

139,610

165,856

188,912

117,087

134,863

151,134

166,278

146,521

153,491

2,027

Total liabilities, Series A preferred shares and shareholders’ equity

238,572

284,250

347,212

385,547

430,612

295,940

324,577

353,743

150,421

181,843

202,086

226,432

151,507

164,811

179,973

190,338

158,522

165,424

2,938